Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) was the recipient of a significant drop in short interest in February. As of February 13th, there was short interest totaling 52 shares, a drop of 74.4% from the January 29th total of 203 shares. Based on an average daily volume of 472 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the company’s shares are sold short. Approximately 0.0% of the company’s shares are sold short. Based on an average daily volume of 472 shares, the days-to-cover ratio is currently 0.1 days.
Gyrodyne Stock Up 1.2%
NASDAQ GYRO traded up $0.11 during trading hours on Friday, reaching $9.01. The company’s stock had a trading volume of 48 shares, compared to its average volume of 416. The firm has a fifty day simple moving average of $8.95 and a 200-day simple moving average of $9.60. Gyrodyne has a 52 week low of $6.80 and a 52 week high of $12.00.
Hedge Funds Weigh In On Gyrodyne
Hedge funds have recently bought and sold shares of the company. Bulldog Investors LLP acquired a new position in shares of Gyrodyne during the third quarter valued at about $601,000. Teton Advisors LLC purchased a new stake in Gyrodyne in the 3rd quarter valued at about $177,000. Susquehanna International Group LLP bought a new position in Gyrodyne during the third quarter valued at about $142,000. Finally, Advisory Services Network LLC purchased a new stake in shares of Gyrodyne during the 3rd quarter valued at $77,000. Institutional investors own 71.36% of the company’s stock.
Gyrodyne Company Profile
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
Featured Stories
- Five stocks we like better than Gyrodyne
- Your name isn’t on our protected list yet
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- Unlocked: Elon Musk’s Next Big IPO
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
